Annual Drug Patent Expirations for AUVELITY
Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and fifteen patents protecting this drug.
This drug has one hundred and seventy-eight patent family members in thirty-two countries.
The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. One supplier is listed for this compound. Additional details are available on the bupropion hydrochloride; dextromethorphan hydrobromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
